Orthocell's Remplir hits 90% success rate
Orthocell's Remplir hits 90% success rate
2 weeks ago
proactiveinvestors.com
Orthocell’s nerve repair device gains Aussie momentum
Orthocell’s nerve repair device gains Aussie momentum
8 months ago
proactiveinvestors.com.au
Orthocell's Remplir moves Into US military healthcare - ICYMI
Orthocell's Remplir moves Into US military healthcare - ICYMI
3 weeks ago
proactiveinvestors.com
Orthocell's Remplir achieves 90% success rate in real-world patient data - ICYMI
Orthocell's Remplir achieves 90% success rate in real-world patient …
2 weeks ago
proactiveinvestors.com
Orthocell flags strong March quarter as US Remplir rollout gathers pace
Orthocell flags strong March quarter as US Remplir rollout gathers pace
4 weeks ago
proactiveinvestors.com
Orthocell secures inclusion for Remplir™ on the prostheses list
Orthocell secures inclusion for Remplir™ on the prostheses list
6 months ago
proactiveinvestors.com
9 News | FDA Grants 510(k) Clearance for Remplir Nerve Product | Orthocell Ltd
9 News | FDA Grants 510(k) Clearance for Remplir Nerve Prod…
4.5K views4 months ago
linkedin.com
2026: The road ahead with Orthocell
4 months ago
theaustralian.com.au
Orthocell CEO Paul Anderson on FDA approval, patient impact and …
4 months ago
proactiveinvestors.com.au
Orthocell records revenues and targets global expansion in 2025
Jan 22, 2025
proactiveinvestors.co.uk
Orthocell appoints second Canadian distributor
6 months ago
theaustralian.com.au
Orthocell’s Remplir scores 81% success rate
8 months ago
themercury.com.au
Long Shortz with Orthocell: Quarterly report depicts promisin…
3 weeks ago
themercury.com.au
Orthocell’s Remplir posts near-90pc success rate
2 weeks ago
theaustralian.com.au
Orthocell unveils positive CelGro® nerve regeneration results in quad…
Feb 26, 2022
proactiveinvestors.co.uk
Remplir sales surge: Orthocell CEO interview
10 months ago
proactiveinvestors.com.au
Orthocell and University of Western Australia cement long-term partne…
Oct 30, 2023
proactiveinvestors.com.au
Orthocell awarded US trademark for Ortho-ATI® cell therapy for treatm…
7 months ago
proactiveinvestors.com
Orthocell sees 4% jump as Remplir used in first US surgery. But is tha…
10 months ago
hotcopper.com.au
Orthocell soars on securing exclusive A$23.1 million global lic…
Jun 27, 2022
proactiveinvestors.com.au
Orthocell surges on receiving Australian regulatory approval for …
Mar 21, 2022
proactiveinvestors.co.uk
Orthocell achieves record A$2.73 million quarterly revenue as Remp…
10 months ago
proactiveinvestors.co.uk
Orthocell expands Remplir™ use in prostate surgery
2 views6 months ago
proactiveinvestors.com.au
Orthocell™ expands Remplir™ reach to more global markets
Apr 29, 2025
proactiveinvestors.com.au
Orthocell launches Remplir in Hong Kong - ICYMI
5 months ago
proactiveinvestors.com.au
Orthocell’s crucial FDA trial proves successful
Dec 2, 2024
theaustralian.com.au
Just the Facts: Orthocell seeks Canadian approval for Remplir™
Feb 3, 2025
proactiveinvestors.com
Just the Facts: Orthocell accelerates global expansion for Remplir™ a…
Jan 21, 2025
proactiveinvestors.com.au
Orthocell study shows Remplir outperforms traditional suture-onl…
11 months ago
proactiveinvestors.com.au
Orthocell receives TGA approval for first Australian-made collagen ner…
Mar 21, 2022
proactiveinvestors.com.au
See more videos
Static thumbnail place holder